Background Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with semaglutide would mitigate these risks is unknown. Methods We randomly assigned patients with type 2 diabetes and chronic kidney disease (...
No comments yet
Be the first to share your thoughts!